Lakefront Biotherapeutics Statistics
NASDAQ: LKFTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
29.51-0.49 (-1.63%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Lakefront Biotherapeutics by the numbers
Lakefront Biotherapeutics has a market capitalization of $1.93 billion based on 65.48M shares outstanding. Its trailing P/E ratio is 2.8. The stock trades 3.8% above its 50-day average and 2.0% below its 200-day average.
Average daily trading volume is 273.30K shares, or about $8.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LKFT valuation vs. peer median
| Metric | LKFT | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.93B | $1.91B | +1% |
| Avg. volume | 273.30K | 1.49M | -82% |
Peer median across 8 companies: SRPT, AGIO, PVLA, SDGR, ADRX, MLYS, PRGO, TRVI.
Valuation
- Market cap
- $1.93B
- P/E (TTM)
- 2.81
- EPS (TTM)
- $10.52
- Shares outstanding
- 65.48M
Price and trading
- Previous close
- 30.00
- Open
- 29.83
- Day range
- 28.66 – 30.13
- 52-week range
- 25.68 – 36.24
- 52-week change
- -14.46%
- Beta
- —
- Volume
- 505.02K
- Average volume
- 273.30K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 1.93B
- Pe
- 2.81
- Forward Pe
- -24.74
- Eps
- 10.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 36.24
- Week52 Low
- 25.68
- Avg Volume
- 273.30K
- Shares Outstanding
- 65.48M
- Ma50
- 28.44
- Ma200
- 30.10
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -18.57%
- Pct From52w Low
- 14.91%